Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer.
Saved in:
| Title: | Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer. |
|---|---|
| Authors: | Volkov NM; City Cancer Center, St.-Petersburg, 197758, Russia., Yanus GA; N.N. Petrov Institute of Oncology, St.-Petersburg, 197758, Russia.; St.-Petersburg Pediatric Medical University, St.-Petersburg, 194100, Russia., Ivantsov AO; N.N. Petrov Institute of Oncology, St.-Petersburg, 197758, Russia., Moiseenko FV; City Cancer Center, St.-Petersburg, 197758, Russia., Matorina OG; City Cancer Center, St.-Petersburg, 197758, Russia., Bizin IV; N.N. Petrov Institute of Oncology, St.-Petersburg, 197758, Russia., Moiseyenko VM; City Cancer Center, St.-Petersburg, 197758, Russia., Imyanitov EN; N.N. Petrov Institute of Oncology, St.-Petersburg, 197758, Russia. evgeny@imyanitov.spb.ru.; St.-Petersburg Pediatric Medical University, St.-Petersburg, 194100, Russia. evgeny@imyanitov.spb.ru. |
| Source: | Investigational new drugs [Invest New Drugs] 2020 Jun; Vol. 38 (3), pp. 894-898. Date of Electronic Publication: 2019 Aug 03. |
| Publication Type: | Case Reports; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
